| Badania |
|
 |
|
|
|
| RESEARCH PROJECT / CENTRAL INNOVATION PROGRAM FOR SMEs |
|
Manufacturing of adult human ABCB5 positive stem cells out of human
primary culture in accordance with GMP for the trial of medication.
|
In this scientific resarch and development project, TICEBA is
developing the manufacturing of adult human ABCB5 positive stem
cells out of human primary culture in accordance with GMP for
the trial of medication with the help of the support of the
German Federation in the context of the
"central innovation program for SMEs".
Acting as scientific advisor is Prof. Markus Frank,
Assistant Professor of Pediatrics, Harvard Medical School,
Associate Physician, Brigham & Women's Hospital Transplantation Research Center,
Brigham & Women's Hospital and Children's Hospital Boston Department of Dermatology, Brigham & Women's Hospital. |
|
| RESEARCH PROJECT / HARVARD |
|
In-vitro and in-vivo differentiation
potential of skin derived human ABCB5-positive stem cells.
|
In this scientific collaboration the differentiation potential of skin derived
ABCB5-positve mesenchymal progenitor cells is being assessed in in-vitro and
in-vivo experiments.
In this research programme TICEBA is an industrial partner
to the laboratory of Prof. Markus Frank,
Assistant Professor of Pediatrics, Harvard Medical School,
Boston/USA, Brigham and Womans Hospital/Havard Medical Scool, Boston/USA. |
|
| RESEARCH PROJECT / ULM |
|
Number and Quality of skin derived
human mesenchymal ABCB5-positive stem cells in correlation of age.
|
In this scientific collaboration the quantity as well as the quality in
correlation to age of human skin derived ABCB5-positve mesenchymal progenitor
cells is being assessed.
In this research programme TICEBA is an industrial
partner to Prof. Dr. Scharffetter-Kochanek M.D., Director of the dermatological hospital
of the university of Ulm. |
|
| RESEARCH PROJECT / HEIDELBERG |
|
Medical system biology of chronic wounds.
|
|
TICEBA is an industrial partner in the research programme "medical system biology of chronic wounds" that is
financed by the federal ministry for education and research and coordinated by the
German cancer research centre (DKFZ) and the
university hospital of Heidelberg, Germany. |
In the system biologic approach, the intrinsic, highly dynamic and complex modalities of wound healing are examined in order to
develop new treatment strategies for the hospital. These strategies are based on combinations of growth factors for temporary or
follow-up application.
The research programme is focussed on an improvement of wound closing with the help of stem cells of the skin. |
| |
